Next Frontiers to Cure Cancer - Integrating Science and Patient Care

Apresentação


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

Mensagem da Presidente da Comissão Científica


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

O ano de 2013 marca a comemoração dos 60 anos do A.C.Camargo Cancer Center. Durante esses anos, esta instituição tem investido de forma consagrada no tratamento, pesquisa e ensino do câncer no Brasil. Estes investimentos fizeram do A.C.Camargo Cancer Center uma das instituições de maior prestígio e credibilidade na área Oncológica em toda a América do Sul.Para comemorarmos estas conquistas, organizamos um evento científico único: "Next Frontiers to Cure Cancer: Integrating Science to Patient Care", que ocorrerá de 13 a 15 de junho no Hotel Renaissance, em São Paulo.

Neste evento foram agregados os melhores profissionais de diferentes áreas, representando a multidisciplinaridade necessária no tratamento de pacientes portadores deste grande grupo de doenças que chamamos de câncer. Profissionais do A.C.Camargo Cancer Center e de respeitadas instituições brasileiras e estrangeiras discutirão o que está na fronteira do conhecimento na área de oncologia. Serão abordados temas relacionados a: tratamento, diagnóstico, patologia molecular, biomarcadores, oncogenômica, novas terapias, cuidados paliativos e medicina personalizada.

Desta forma, é com grande entusiasmo que convidamos a todos para participar deste evento memorável, que nos coloca mais perto das conquistas na área oncológica e das possibilidades de oferecer aos nossos pacientes o que existe de mais avançado no tratamento oncológico.

Dra. Vilma Martins
Head - Molecular & Cell Biology Group
A.C.Camargo Cancer Center

Sobre o evento


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

TEMAS CENTRAIS

- Câncer de Mama
- Câncer Ginecológico
- Câncer do Aparelho Digestivo Alto
- Câncer Colorretal
- Câncer de Cabeça e Pescoço
- Câncer de Pulmão
- Câncer de Próstata
- Melanoma

Os temas centrais serão distribuídos entre os seguintes módulos:

1. Introdução do tema (diagnóstico, tratamento de doença local, tratamento de doença localizada, tratamento de doença metastática)
2. Rastreamento (quando aplicável)
3. Refinamentos no diagnóstico anátomo patológico
4. Diagnóstico molecular
5. Tratamento personalizado

PÚBLICO ALVO

- Médicos (oncologistas clínicos, cirurgiões oncológicos, radioterapeutas, patologistas e cientistas da área básica) alunos de graduação e pós graduação da área de oncologia, residentes médicos e não médicos na área oncológica.

- Pacientes e associações que os possam representar.

- Gestores, tanto do setor público como privado, relacionado direta ou indiretamente com profissionais de saúde ou pacientes portadores de neoplasias.

APRESENTAÇÃO DE TRABALHOS CIENTÍFICOS E ANAIS

Contaremos com comitê científico formado por quatro júris externos à instituição para a seleção de resumos a serem apresentados no congresso.

Dentre os selecionados, os 10 melhores serão convidados a realizar uma apresentação oral. A melhor apresentação será premiada com o prêmio "Antônio Prudente".

Todos os resumos selecionados comporão os anais do congresso a serem publicados como um volume específico da revista Applied Cancer Research.

Para submeter o seu resumo, clique aqui e conheça o regulamento e mais informações.



O A.C.Camargo Cancer Center, desde sua fundação em 1953, vem contribuindo de forma substancial na formação oncológica, não apenas brasileira, mas também latinoamericana. Ao longo desses 59 anos, mais de mil profissionais especializaram-se pela Escola de Cancerologia de Hospital. Programas de pós graduação latu e strictu sensu são oferecidos de forma regular, assim como vários simpósios realizados anualmente. Inserido neste contexto e, em decorrência dos bons resultados obtidos com os simpósios internacionais organizados nos anos anteriores, o Hospital A.C.Camargo tem a honra de comunicar a realização deste evento comemorativo dos seus 60 anos intitulado "NEXT FRONTIERS TO CURE CANCER- INTEGRATING SCIENCE AND PATIENT CARE".

O evento fará a abordagem integral do paciente oncológico desde o diagnóstico anátomo patológico, molecular e radiológico, passando pelo tratamento local e sistêmico, alem das mais recentes abordagens em pesquisa básica sobre o câncer.

Data


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

Local


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

Palestrantes e Convidados


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

Clifford A. Hudis, M.D., FACP
Chief of the Breast Cancer Medicine Center
Memorial Sloan-Kettering Cancer Center New York, USA

Uri Tabori, M.D.
NeuroOncologist
Division of Haematology, Oncology
University of Toronto
Toronto, Canada

Jeffrey Myers, M.D., PHD
Director of Research, Department of Head and Neck Surgery, Division of Surgery
The University of Texas MD Anderson Cancer Center
Houston, TX

Natasha Leighl, M.D., M.Sc
Medical Oncologist
University Health Network
Toronto Canada

George Chang, M.D., MS, FACS, FASCRS
Director of Clinical Operations, Minimally Invasive and New Technologies in Oncologic Surgery Program
The University of Texas MD Anderson Cancer Center
Houston, TX

Wadih Arap, M.D., PHD
Stringer Professor of Medicine and Experimental Diagnostic Imaging
Deputy Department Chair of Genitourinary Medical Oncology
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center, Houston, TX

Renata Pasqualine, PHD
Helen Buchanan & Stanley Seeger Professor of Medicine and Experimental Diagnostic Imaging, Department of Genitourinary Medical Oncology - Research, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center, Houston, TX

Giovanni Pellacani, MD
Professor of Dermatology,
Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.

Rafael E. Pollock, M.D., PHD
Professor of Molecular and Cellular Oncology
The University of Texas Health Sciences Center Houston
Professor of Surgery, Department of Surgery
The University of Texas MD Anderson Cancer Center, Houston, TX

Luis Parada, PHD
Professor and Chairman
Developmental Biology
UT Southwestern Medical Center, Texas

Gary M Rodin, M.D.
Full Professor
Princess Margaret Hospital
University of Toronto, Canada

Patrizia Paterlini Bréchot, M.D., PHD
Professor of Cell Biology/Oncology
University of Paris Descartes
Director of INSERM Unit 807.com

Eduardo Franco, PHD
James McGill Professor in the Departments of Oncology and Epidemiology & Biostatistics
Director, Division of Cancer Epidemiology, and
Interim Chair, Department of Oncology
Faculty of Medicine, McGill University, Montreal, Canada.

Toshikazu Ushijima, M.D., PHD
Chief of Division of Epigenomics
Senior Deputy Director
National Cancer Center Research Institute, Japan

Vikas Kundra, MD, PHD
Director Molecular Imaging, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Kie Kian Ang, M.D., Ph.D.
Deputy Head, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX,
VP- GLOBAL ACADEMIC PROGRAMNS- MD ANDERSON CANCER CENTER

Oreste Gentilini, M.D.
Deputy Director, Division of Breast
European Institute of Oncology

Comissão Científica


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

Dra. Vilma Martins
Dr. Fernando Augusto Soares
Dr. Rafael Malagoli Rocha
Dr. Marcello Ferretti Fanelli
Dra. Solange Sanches
Dr. Luiz Paulo Kowalski
Dr. Glauco Baiocchi Neto

Programação


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

Summarized Program

Para ver a programação resumida com os temas das mesas e os chairs, clique aqui.
Ou, se preferir, consulte a programação completa navegando pelas abas abaixo.


Preliminary Program

13/06/13, Thursday
Morning
Main Room - BREAST
Chairs - Marcello Fanelli and Maria do Socorro Maciel (A.C.Carmargo Cancer Center)
08:00 - 08:15 Marcello Fanelli and Vilma Martins
(A.C.Camargo Cancer Center)
Opening ceremony
08:15 - 08:30 Elvira Ferreira Marques
(A.C.Camargo Cancer Center)
Optimizing the radiological diagnosis
08:30 - 08:45 Maria Nirvana Formiga
(A.C.Camargo Cancer Center)
The impact of screening for genetic mutations
08:45 - 09:00 Dirce Carraro
(A.C.Camargo Cancer Center)
Progression of In situ ductal carcinoma: Molecular alterations in cells of breast ductal carcinoma occur before morphological manifestation of invasion
09:00 - 09:15 Marcello Fanelli
(A.C.Camargo Cancer Center)
mTOR pathways as potential targets in hormone therapy in breast cancer
09:15 - 09:30 Discussion
09:30 - 10:00 Coffee break and poster presentation
10:00 - 10:30 Clifford Hudis
(Memorial Sloan-Kettering Cancer Center)
Obesity, Inflammation, and Breast Cancer
10:30 - 10:45 Selected posters: oral presentation
10:45 - 11:00 Victor Piana
(A.C.Camargo Cancer Center)
Conference- Genetic signatures X immunohistochemistry and pathological data
11:00 - 11:15 Almir Galvão Bitencourt
(A.C.Camargo Cancer Center)
Selected posters: oral presentation
Multiparametric evaluation of breast lesions using functional imaging methods
11:15 - 11:30 Discussion
13/06/13, Thursday
Main Room - Conference
11:45 - 12:30 Clifford Hudis
(Memorial Sloan-Kettering Cancer Center)
Systemic Therapy Today: Biology Leading The Way
13/06/13, Thursday
Afternoon
Main Room - UROLOGY
Chairs: Gustavo Guimarães and Aldo Lourenço Dettino (A.C.Camargo Cancer Center)
14:00 - 14:15 Gustavo Guimarães
(A.C.Camargo Cancer Center)
Prostate cancer screening: myths and truth
14:15 - 14:45 Vikas Kundra
(MD Anderson Cancer Center, USA)
Imaging in prostate cancer staging: when and how?
14:45 - 15:00 Gustavo Guimarães
(A.C.Camargo Cancer Center)
The treatment of localized low risk disease - future perspectives
15:00 - 15:15 Rodrigo Campos
(A.C.Camargo Cancer Center)
The treatment of localized high risk disease - future perspectives
15:15 - 15:30 Discussion
15:30 - 16:00 Coffee break and poster presentation
16:00 - 16:20 Maria Letícia Gobo
(A.C.Camargo Cancer Center)
Advancements in radiotherapy for prostate cancer
16:20 - 16:40 Maria Nirvana Formiga
(A.C.Camargo Cancer Center)
Androgen receptors: recent advancements in treatment
16:40 - 17:00 José Augusto Rinck Jr
(A.C.Camargo Cancer Center)
Next generation systemic therapies in prostate cancer
17:00 - 17:20 Stenio Zequi
(A.C.Camargo Cancer Center)
Treatment of the erectile dysfunction after cancer treatment
17:20 - 17:30 Discussion
13/06/13, Thursday
Main Room - Conference
17:45 - 18:30 Jeremy Squire
(Kingston General Hospital & Queen's University, Canada)
PTEN loss in early and advanced of prostate cancer: example of rapid transition of a biomarker from bench to bedside
14/06/13, Friday
Morning
Main Room - GASTROINTESTINAL TUMORS
Chairs: Felipe Coimbra and Fabio Nasser (A.C.Camargo Cancer Center)
08:00 - 08:30 Jaffer Ajani
(MD Anderson Cancer Center, USA)
Molecular biology of esophageal adenocarcinoma
08:30 - 08:45 Eduardo Lima
(A.C.Camargo Cancer Center)
New diagnostic tools in esophageal carcinoma (PET)
08:45 - 09:00 Fauze Maluf Filho
(FM-Universidade de São Paulo)
Endoscopic treatment of initial lesions
09:00 - 09:20 Felipe Coimbra
(A.C.Camargo Cancer Center)
Multimodal treatment: squamous cell x adenocarcinoma
09:20 - 09:30 Discussion
09:30 - 10:00 Coffee break and poster presentation
10:00 - 10:20 Toshikazu Ushijima
(National Cancer Center Research Institute)
H. pylori and environmental factors in gastric cancer
10:20 - 10:40 Maria Dirlei S. Begnami
(A.C.Camargo Cancer Center)
Molecular targets and HER2 in gastric cancer
10:40 - 11:00 Wilson Luiz da Costa Jr
(A.C.Camargo Cancer Center)
Ideal staging of gastric neoplasias
11:00 - 11:20 Jaffer Ajani
(MD Anderson Cancer Center, USA)
Perioperative X adjuvant therapy: best evidences in gastric cancer
11:20 - 11:30 Discussion
14/06/13, Friday
Main Room - Conference
11:45 - 12:30 Eduardo Franco
(McGill University, Canada)
The tyranny of evidence-based medicine in cancer prevention and control
14/06/13, Friday
Afternoon
Main Room - EPIDEMIOLOGY OF HEAD AND NECK CARCINOMAS
Chairs: Luiz Paulo Kowalski and Thiago Bueno Oliveira (A.C.Camargo Cancer Center)
14:00 - 14:30 Luiz Paulo Kowalski
(A.C.Camargo Cancer Center)
A.C.Camargo contribution in the management of head and neck carcinomas
14:30 - 15:00 Enrique M. Boccardo Pierulivo
(ICB- USP)
HPV and tumor microenvironment
15:00 - 15:30 Silvia Rogatto
(A.C.Camargo Cancer Center)
Conference: Familial predisposition and carcinogenesis in head and neck tumors
15:30 - 16:00 Coffee break and poster presentation
16:00 - 16:15 Ulisses R. Nicolau
(A.C.Camargo Cancer Center)
PET-CT as a predictor factor of response in head and neck carcinomas
16:15 - 16:30 Antonio Hugo Campos
(A.C.Camargo Cancer Center)
From optic microscopy to molecular pathology
16:30 - 16:45 Aline Lauda Freitas Chaves
(Hospital São João de Deus)
Difficulties on the implementation of National Guidelines in Head and Neck Cancer
16:45 - 17:00 José Guilherme Vartanian
(A.C.Camargo Cancer Center)
The classical and modern: how to balance the diagnostic technology
17:00 - 17:30 Eduardo Franco
(McGill University, Canada)
Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy
14/06/13, Friday
Main Room - Conference
17:45 - 18:30 Jeffrey Myers
(MD Anderson Cancer Center, USA)
Genomic alterations in head and neck cancer: what to do about them?
15/06/13, Saturday
Morning
Main Room - MELANOMA
Chairs: Gisele Rezze and José Augusto Rinck Jr (A.C.Camargo Cancer Center)
08:00 - 08:15 Gisele Rezze
(A.C.Camargo Cancer Center)
The research of cutaneous oncology at A.C.Camargo
08:15 - 08:45 João Duprat
(A.C.Camargo Cancer Center)
Surgery of advanced melanoma, perfusion, infusion and local treatment
08:45 - 09:15 Giovanni Pellacani
(University of Modena and Reggio Emilia)
Advanced methods for diagnosis of melanomas
09:15 - 09:30 Discussion
09:30 - 10:00 Coffee break
10:00 - 10:15 Mariana Macedo
(A.C.Camargo Cancer Center)
BRAF, MAPK, RAS and PI3K in melanoma
10:15 - 10:30 José Augusto Rink Jr
(A.C.Camargo Cancer Center)
New targeted therapies in melanoma
10:30 - 10:45 Milton Barros
(A.C.Camargo Cancer Center)
Immunotherapy principles applied in melanoma treatment
10:45 - 11:00 André Molina
(A.C.Camargo Cancer Center)
Update in dermatofibrosarcoma
11:00 - 11:15 Bianca Costa S. de Sá
(A.C.Camargo Cancer Center)
Familial Melanoma
11:15 - 11:30 Discussion
13/06/13, Thursday
Main Room - Conference
11:45 - 12:30 Wadih Arap and Renata Pasqualini
(MD Anderson Cancer Center, USA)
Ligand-directed therapy and molecular imaging based on in vivo phage display technology
13/06/13, Thursday
Morning
Room A - LUNG
Chairs: Jefferson Gross and Vladmir Lima (A.C.Carmargo Cancer Center)
08:00 - 08:15 Jefferson Gross
(A.C.Camargo Cancer Center)
Lung cancer - A.C.Camargo experience
08:15 - 08:30 Isabela Werneck da Cunha
(A.C.Camargo Cancer Center)
Molecular pathology of lung cancer
08:30 - 08:45 Ricardo Fogarolli
(A.C.Camargo Cancer Center)
Stereotaxic radiotherapy in the treatment of lung cancer
08:45 - 09:15 Natasha Leighl
(University Health Network, Canada)
The influence of patient age in treatment decision for non-small- cell lung cancer
09:15 - 09:30 Discussion
09:30 - 10:00 Coffee break and poster presentation
10:00 - 10:30 Carlos Gil
(INCA)
The epidemiology of lung cancer
10:30 - 10:45 Natasha Leighl
(University Health Network, Canada)
How to evaluate the real impact in global survival based on the recent advances in diagnosis, staging and treatment of non-small- cell lung cancer
10:45 - 11:15 Patrizia Paterlini Bréchot
(University of Paris Descartes, France)
Molecular analyses of circulating tumor cells: a "liquid biopsy" non-invasive theranostic approach to improve follow up and treatment of patients with cancer
11:15 - 11:30 Vikas Kundra
(MD Anderson Cancer Center)
Molecular Imaging - near future
13/06/13, Thursday
Afternoon
Room A - BREAST
Chairs: Maria do Socorro Maciel and Solange Moraes Sanches (A.C.Camargo Cancer Center)
14:00 - 14:15 Oreste Gentilini
(European Institute of Oncology, Italy)
Surgery of very young women: what is different?
14:15 - 14:30 Maria do Socorro Maciel
(A.C.Camargo Cancer Center)
Management of surgical positive margins after conservative breast surgery
14:30 - 14:45 Oreste Gentilini
(European Institute of Oncology, Italy)
Management of the axilla in the presence of positive sentinel lymph node
14:45 - 15:00 Oreste Gentilini
(European Institute of Oncology, Italy)
Intraoperative radiotherapy: EIO experience
15:00 - 15:15 Maria Aparecida Conte Maia
(A.C.Camargo Cancer Center)
Emergent forms of radiotherapy
15:15 - 15:30 Discussion
15:30 - 16:00 Coffee break and poster presentation
16:00 - 16:15 Solange Moraes Sanches
(A.C.Camargo Cancer Center)
Improving HER2 inhibition in the treatment of breast cancer
16:15 - 16:30 Tadeu Ferreira de Paiva Jr
(A.C.Camargo Cancer Center)
Antiangiogenic agents in breast cancer treatment
16:30 - 16:45 Gustavo Ismael
(Hospital Amaral Carvalho)
Neoadjuvant Therapy for Breast Cancer: When and Why?
16:45 - 17:15 Vladmir Lima
(Hospital Amaral Carvalho)
Immune signatures: complementing the complexity of breast cancer
17:15 - 17:30 Discussion
14/06/13, Friday
Morning
Room A - GYNECOLOGICAL TUMORS
Chairs: Glauco Baiocchi Neto and Alexandre Balieiro (A.C.Camargo Cancer Center)
08:00 - 08:15 Maria Nirvana Formiga
(A.C.Camargo Cancer Center)
Rational and implications of the identification of genetic mutations in ovary cancer
08:15 - 08:30 Louise de Brot Andrade
(A.C.Camargo Cancer Center)
The impact of molecular classification in ovary cancer
08:30 - 08:45 Solange Moraes Sanches
(A.C.Camargo Cancer Center)
Personalized treatment in ovary cancer: is it possible?
08:45 - 09:00 Andrea Guimarães
(A.C.Camargo Cancer Center)
Angiogenesis as a target in the treatment of initial and recurrent ovary cancer
09:00 - 09:15 Robert Coleman
(MD Anderson Cancer Center, USA)
Minimal invasive surgery in gynecological cancer
09:15 - 09:30 Discussion
09:30 - 10:00 Coffee break and poster presentation
10:00 - 10:15 Enrique Boccardo
(ICB- USP)
HPV and cervical cancer
10:15 - 10:30 Glauco Baiocchi Neto
(A.C.Camargo Cancer Center)
Surgical treatment of epithelial ovary cancer: primary cytoreduction versus neoadjuvant chemotherapy
10:30 - 10:45 Robert Coleman
(MD Anderson Cancer Center, USA)
Surgical treatment of relapsed ovarian cancer- secondary cytoreduction: for whom and in which moment
10:45 - 11:00 Audrey Tsunoda
(Hospital do Câncer de Barretos)
Advanced cervical cancer: current status and future perspectives
11:00 - 11:15 Robert Coleman
(MD Anderson Cancer Center, USA)
Sentinel lymph node in gynecological cancer
11:15 - 11:30 Discussion
14/06/13, Friday
Afternoon
Room A - GASTROINTESTINAL TUMORS
Chairs: Felipe Coimbra and Rubens Chojniak (A.C.Camargo Cancer Center)
14:00 - 14:15 Paula Nicole Barbosa Pinto
(A.C.Camargo Cancer Center)
Staging pancreatic cancer
14:15 - 14:30 Maria Dirlei S. Begnami
(A.C.Camargo Cancer Center)
Prognostic markers in pancreatic cancer
14:30 - 14:45 Milton Barros
(A.C.Camargo Cancer Center)
Pre-surgical therapeutic options in potentially resectable pancreatic tumors
14:45 - 15:00 Felipe Coimbra
(A.C.Camargo Cancer Center)
Resection after neoadjuvant treatment for locally advanced disease
15:00 - 15:15 Jaffer Ajani
(MD Anderson Cancer Center, USA)
Pancreatic cancer: why is it so difficult to treat?
15:15 - 15:30 Discussion
15:30 - 16:00 Coffee break and poster presentation
16:00 - 16:15 Heber Ribeiro
(A.C.Camargo Cancer Center)
Surgical diagnosis and prognostic factors in neuroendocrine tumors
16:15 - 16:45 Milton Barros
(A.C.Camargo Cancer Center)
Pancreatic neuroendocrine tumors: signaling pathways and targeted therapies
16:45 - 17:00 Bruno Vilhena
(INCA)
GIST: perspectives after imatinib therapy
17:15 - 17:30 Discussion
15/06/13, Saturday
Morning
Room A - SUPPORTIVE THERAPIES AND PSYCHO-ONCOLOGY
Chairs: Maria Teresa Cruz Lourenço and Sandra Caires (A.C.Camargo Cancer Center), Ana Georgia C. de Melo (Susan G. Komen Breast Cancer Foundation and Associação Brasileira de Cuidados Paliativos)
08:00 - 08:20 Sandra Caires
(A.C.Camargo Cancer Center)
The A.C.Camargo Hospital model for palliative care
08:20 - 08:45 Maria Teresa C. Lourenço
(A.C.Camargo Cancer Center)
Communicating bad news
08:45 - 09:30 Gary M. Rodin
(Princess Margaret Hospital, Canada)
Palliative sedation and assisted death: Clinical indications and controversies
09:30 - 10:00 Coffee break
10:00 - 10:30 Fabiana Gomes de Campos
(A.C.Camargo Cancer Center)
Palliative care in pediatrics (Brazilian focus) - where are we?
10:30 - 11:00 Elisabete Carrara de Angelis
(A.C.Camargo Cancer Center)
Voice and swallowing rehabilitation in oncology
11:00 - 11:30 Lica Arakawa-Sugueno
(HC-FMUSP)
Manual lymphatic drainage and its impact in laryngeal edema
13/06/13, Thursday
Morning
Room B - PEDIATRICS/POSTERS
Chair: Cecilia Maria L. da Costa (A.C.Camargo Cancer Center)
08:00 - 08:15 Cecilia Maria L. da Costa
(A.C.Camargo Cancer Center)
The pediatric cancer - A.C.Camargo experience
08:15 - 08:45 Célia Antoneli
(Centro Infantil Boldrini)
Advances in the treatment of retinoblastoma in South America
08:45 - 09:00 Mayra Castro
(A.C.Camargo Cancer Center)
Selected posters: oral presentation
Validation os somatic and de novo alterations identifies by exome sequencing in sporadis wilm's tumor
09:00 - 09:15 Natalie Kelner
(A.C.Camargo Cancer Center)
Selected posters: oral presentation
Incidence of occult metastasis and predictive value of histopathologic parameter in early carcinoma of oral tongue and floor of the mouth
09:15 - 09:30 Camila Lopes Ramos
(A.C.Camargo Cancer Center)
Selected posters: oral presentation
miR21 as a biomarker to predict response to neoadjuvant therapy in patients with rectal cancer
09:30 - 10:00 Coffee break and poster presentation
Room B - GASTROINTESTINAL TUMORS: COLORECTAL
Chairs: Samuel Aguiar Jr and Celso Abdon Mello (A.C.Camargo Cancer Center)
10:00 - 10:15 Samuel Aguiar Jr
(A.C.Camargo Cancer Center)
Screening of colorectal carcinomas (CRC)
10:15 - 10:30 Erika Maria Monteiro
(A.C.Camargo Cancer Center)
Hereditary colorectal cancer: how to improve diagnosis in clinical practice?
10:30 - 10:45 Mariana Macedo
(A.C.Camargo Cancer Center)
Molecular classification and biomarkers in CRC
10:45 - 11:00 Celso Abdon Mello
(A.C.Camargo Cancer Center)
Molecular markers and adjuvant therapy in CRC
11:00 - 11:15 Helano Freitas
(A.C.Camargo Cancer Center)
Molecular pathways associated to CRC: beyond K-ras
11:15 - 11:30 Discussion
13/06/13, Thursday
Afternoon
Room B - GASTROINTESTINAL TUMORS: COLORECTAL
Chairs: Samuel Aguiar Jr and Marcelo Calil Netto (A.C.Camargo Cancer Center)
14:00 - 14:15 Marcello Fanelli
(A.C.Camargo Cancer Center)
Clinical impact of first line anti-EGFR therapy in metastatic CRC
14:15 - 14:30 Marcelo Calil Netto
(A.C.Camargo Cancer Center)
Understanding the resistance to EGFR inhibitors: impact on future strategies
14:30 - 14:45 Tadeu Ferreira de Paiva Jr
(A.C.Camargo Cancer Center)
Antiangiogenic therapy: impact upon invasion, progression and metastasis
14:45 - 15:15 Samuel Aguiar Jr
(A.C.Camargo Cancer Center)
Mini conference: Molecular approach in CRC- an example to be followed
15:15 - 15:30 Discussion
15:30 - 16:00 Coffee break and poster presentation
16:00 - 16:15 Rubens Chojniak
(A.C.Camargo Cancer Center)
Challenges in the clinical staging of rectal cancer
16:15 - 16:30 Ricardo Fogarolli
(A.C.Camargo Cancer Center)
Neoadjuvant radiotherapy: choosing the right patient for new schemes
16:30 - 16:45 George Chang
(MD Anderson Cancer Center)
Strategies and limitations in sphincter preservation for rectal cancer
16:45 - 17:15 George Chang
(MD Anderson Cancer Center)
Mini Conference: Robotic surgery in rectal cancer
17:15 - 17:30 Discussion
14/06/13, Friday
Morning
Room B - UROLOGY
Chairs: Gustavo Guimarães and José Augusto Rinck Jr (A.C.Camargo Cancer Center)
08:00 - 08:15 Stenio Zequi
(A.C.Camargo Cancer Center)
Renal tumors (diagnosis and treatment)- future therapy
08:15 - 08:30 Thiago Bueno Oliveira
(A.C.Camargo Cancer Center)
The evolution of systemic therapy in renal cancer: from immunotherapy to target therapy: future perspectives
08:30 - 08:45 Marcos Dall'Oglio
(HC-FMUSP)
T1G3 - Which is the best therapeutic option and what is new?
08:45 - 09:00 Aldo Abade Dettino
(A.C.Camargo Cancer Center)
Bladder tumors: neoadjuvant X adjuvant therapy: best evidences and therapeutic options in patients with restriction to platinum agents
09:00 - 09:15 Robson Ferrigno
(Hospital São José)
Current role and future expectations of bladder preservation protocols
09:15 - 09:30 Discussion
09:30 - 10:00 Coffee break and poster presentation
10:00 - 10:15 Stenio Zequi
(A.C.Camargo Cancer Center)
Testicular tumors - preservation of physiological functions and fertility
10:15 - 10:30 José Augusto Rinck Jr
(A.C.Camargo Cancer Center)
Testicular tumor: best management of relapsed disease
10:30 - 10:45 Ademar Lopes
(A.C.Camargo Cancer Center)
Treatment and prognostic factors in penile cancer
10:45 - 11:00 Fernando Soares
(A.C.Camargo Cancer Center)
Penile cancer - molecular pathogenesis
11:00 - 11:15 Silvia Rogatto
(A.C.Camargo Cancer Center)
Distinct molecular pathways in penile carcinomas according to HPV infection
11:15 - 11:30 Discussion
14/06/13, Thursday
Afternoon
Room B - SOFT TISSUE AND BONE TUMORS
Chairs: Antônio Nascimento and Paulo Roberto S. Filho (A.C.Camargo Cancer Center)
14:00 - 14:30 Rafael Pollock
(MD Anderson Cancer Center, USA)
Fibromatosis/desmoid tumors: the state of art and future perspectives
14:30 - 14:45 Ademar Lopes
(A.C.Camargo Cancer Center)
Internal hemipelvectomy in the treatment of bone malignancies
14:45 - 15:00 Celso Abdon Mello
(A.C.Camargo Cancer Center)
Soft tissue sarcomas: advancements in systemic treatment
15:30 - 16:00 Coffee break and poster presentation
Room B - SOFT TISSUE SARCOMAS
Chairs: Ademar Lopes and Renata M. Takahashi (A.C.Camargo Cancer Center)
16:00 - 16:20 Isabela Werneck da Cunha
(A.C.Camargo Cancer Center)
Molecular diagnosis of sarcomas
16:20 - 16:40 Samuel Aguiar Jr
(A.C.Camargo Cancer Center)
Preoperative therapies for extremity soft tissue sarcomas - A.C.Camargo experience
16:40 - 17:00 Rafael Pollock
(MD Anderson Cancer Center, USA)
Recent approaches and results in sacomas' treatment
17:00 - 17:20 Ranyell M. Spencer
(A.C.Camargo Cancer Center)
Prognostic and predictive factors in extremity soft tissue sarcomas - A.C.Camargo experience
17:20 - 17:30 Discussion
15/06/13, Saturday
Morning
Room B - LOCO-REGIONAL TREATMENT OF HEAD AND NECK CANCER
Chairs: Mauro K. Ikeda and Ulisses Ribaldo Nicolau (A.C.Camargo Cancer Center)
08:00 - 08:15 Luiz Paulo Kowalski
(A.C.Camargo Cancer Center)
Head and Neck treatment in the last decade
08:15 - 08:30 Aldo Stamm
(Hospital Edmundo Vasconcelos)
Video-assisted surgeries
08:30 - 08:45 Douglas Guedes
(A.C.Camargo Cancer Center)
Reirradiation and intraoperative radiotherapy
08:45 - 09:00 Andre Lopes Carvalho
(Hospital do Câncer de Barretos)
Translational Research in Head and Neck Oncology
09:00 - 09:30 Kian Ang
(MD Anderson Cancer Center, USA)
HPV-releated carcinoma: demographics and therapeutic challenges
09:30 - 10:00 Coffee break
10:00 - 10:15 Roger Chammas
(FM - USP)
Biological factors related to tumor progression and its (lack of) response to therapy
10:15 - 10:30 Thiago Bueno Oliveira
(A.C.Camargo Cancer Center)
Resistance to anti-EGF
10:30 - 10:45 Gilberto de Castro Jr
(ICESP)
Resistance and sensitivity to chemotherapy
10:45 - 11:00 Kian Ang
(MD Anderson Cancer Center, USA)
Strategies to overcome radioresistance
11:00 - 11:30 Jeffrey Myers
(MD Anderson Cancer Center, USA)
Overcoming mutant p53 mediated resistance in head and neck cancer
13/06/13, Thursday
Morning
Room C - P53 AND LI-FRAUMENI SYNDROME / POSTERS
Chair: Maria Isabel Achatz - A.C.Carmargo Cancer Center)
08:00 - 08:45 Maria Isabel Achatz
(A.C.Camargo Cancer Center)
The TP53 p.R337H mutation and the high incidence of Li-Fraumeni Syndrome in Brazil
08:45 - 09:30 Uri Tabori
(The Hospital for Sick Children, Canada)
The Yin and Yang of pediatric cancer genetics, the role of TP53
09:30 - 10:00 Coffee break and poster presentation
10:00 - 10:45 Irina Kerkis
(Instituto Butantan)
Isolation and characterization of cancer stem cells from the patients with the Li-Fraumeni Syndrome
10:45 - 11:00 Lucas Leite Cunha
(UNICAMP)
Selected posters: Oral presentation
Impact of immune cells and cycloxigenase expression oucome of patients with differentiated thyroid cancer
11:00 - 11:15 Mateus de Camargo Barros Filho
(A.C.Camargo Cancer Center)
Selected posters: Oral presentation
Differential expression profile of papillary thyroid carcinoma harboring BRAFV66E mutation
11:15 - 11:30 Debora Zuccari
(FM São José do Rio Preto)
Selected posters: Oral presentation
Melatonin as a therapeutic agent in breast cancer
13/06/13, Thursday
Afternoon
Room C - GLIOMAS: FROM TREATMENT TO MOLECULAR DISCOVERIES
Chairs: Vilma Martins and Paulo Sanematsu Jr (A.C.Camargo Cancer Center)
14:00 - 14:15 Paulo Sanematsu Jr
(A.C.Camargo Cancer Center)
Gliomas - surgical approaches
14:15 - 14:30 Douglas Guedes
(A.C.Camargo Cancer Center)
Advances and perspectives in CNS radiotherapy
14:30 - 15:15 Uri Tabori
(The Hospital for Sick Children, Canada)
Novel applications of telomere maintenance in gliomagenesis
15:15 - 15:30 Discussion
15:30 - 16:00 Coffee break and poster presentation
16:00 - 16:15 Ana Carolina Levy
(A.C.Camargo Cancer Center)
Therapeutic challenges in glioblastoma treatment
16:15 - 16:45 Vilma Martins
(A.C.Camargo Cancer Center)
The complex prion protein-HOP as a new target in glioblastoma treatment
16:45 - 17:30 Luis Parada
(UT Southwestern Medical Center)
Propagation of tumor stem cells after temozolomide treatment
14/06/13, Friday
Morning
Room C - GENOMICS AND PROTEOMICS: POWERFUL TOOLS FOR CANCER RESEARCH
Chairs: Emmanuel Dias Neto and Dirce Carraro (A.C.Camargo Cancer Center)
08:00 - 08:45 Renata Pasqualini and Wadih Arap
(MD Anderson Cancer Center, USA)
Mapping metastasis-related molecular addresses by in vivo phage display
08:45 - 09:30 Dirce Maria Carraro
(A.C.Camargo Cancer Center)
Triple Negative and Hereditary Breast Cancer: A genomics perspective
09:30 - 10:00 Coffee break and poster presentation
10:00 - 10:45 Emmanuel Dias Neto
(A.C.Camargo Cancer Center)
Sequencing our other genomes: metagenomics of oral cancer
10:45 - 11:30 Sandro José de Souza
(Brain Institute, Universidade Federal do Rio Grande do Norte)
From personalized to cancer genomics
14/06/13, Thursday
Afternoon
Room C - MOLECULAR ASPECTS OF GYNECOLOGICAL CANCERS / POSTERS
Chairs: Rafael Malagoli and Fernando Soares (A.C.Camargo Cancer Center)
14:00 - 14:45 Jeremy Squire
(Squire Kingston General Hospital & Queen's University, Canada)
Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer
14:45 - 15:30 Rafael Malagoli
(A.C.Camargo Cancer Center)
Molecular aspects of squamous cell carcinoma of the vulva
15:30 - 16:00 Coffee break and poster presentation
16:00 - 16:45 Fernando Soares
(A.C.Camargo Cancer Center)
Morphological pathogenesis of cervical cancer: where we stand?
16:45 - 17:00 Patricia Peresi
(A.C.Camargo Cancer Center)
Selected posters: Oral presentation
The A.C.Camargo Cancer Center prevention program
17:00 - 17:15 Iara Sant'Ana Rodrigues
(A.C.Camargo Cancer Center)
Selected posters: Oral presentation
Characterizing epithelial mesenchymal transition in vulva cancer and its relationship with HPV
17:00 - 17:15 Vanessa J. Victorino
(Universidade Federal de Londrina)
Selected posters: Oral presentation
Clinical insights from adiponectin analysis in breast cancer patients reveal its anti-inflamatory properties in non obese women
15/06/13, Saturday
Morning
Room C - EPIGENETICS AND CIRCULATING TUMOR CELLS
Chairs: Silvia Rogatto and Ludmila Chinen (A.C.Camargo Cancer Center)
08:00 - 08:45 Toshikazu Ushijima
(National Cancer Center Research Institute, Japan)
Genetics and Epigenetics basis of personalized therapy of gastric cancer
08:45 - 09:15 Ana Krepischi
(A.C.Camargo Cancer Center)
Cancer epigenomics: genome-wide profiling of human cancer methylomes
09:15 - 09:30 Ludmila Chinen
(A.C.Camargo Cancer Center)
Circulating tumor cells: pilot studies at A.C.Camargo Hospital
09:30 - 10:00 Coffee break
10:00 - 10:45 Patrizia Paterlini Bréchot
(University of Paris Descartes, France)
Circulating tumor cells and translational research: which view for their clinical use in predictive oncology?
10:45 - 11:30 Miriam Jasiulionis
(UNIFESP)
Epigenetic alterations: Linking sustained stress to melanocyte malignant transformation

Envio de Resumos


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

Informações Gerais
Serão aceitos apenas trabalhos científicos originais. Podem ser enviados resumos não publicados em revistas científicas e que já foram apresentados em outros eventos científicos. Os resumos devem ser submetidos em inglês. A data limite para envio dos resumos será 10 de Maio de 2013.

Os trabalhos serão divididos em duas categorias: comunicações científicas e relatos de casos. Apenas relatos de casos de valor científico e instrutivo de alta relevância serão considerados. Os resumos serão avaliados anonimamente por uma comissão científica e os aprovados apresentados na forma de poster, os 10 melhores posters serão premiados. Os trabalhos que não atenderem os padrões de qualidade exigidos pela comissão científica serão rejeitados.

A confirmação de aceite ou rejeição do resumo pela comissão científica será enviada para o autor principal por e-mail até 20 de Maio de 2013, juntamente com a instrução para apresentação oral ou em forma de pôster.

Instruções para Submissão dos Resumos
Os resumos devem ser enviados como anexos (um arquivo para cada trabalho) para o seguinte endereço de e-mail: nextfrontiers@accamargo.org.br.

Por favor, notar que não será possível editar o resumo após seu envio ou aceite, motivo pelo qual solicitamos especial atenção dos autores para as informações a seguir.

Por favor, informar:
Categoria do resumo:
1. Comunicação científica
2. Relato de caso

Identificação: 1. Nome, endereço de e-mail, instituição a que pertence o primeiro autor (ou autor correspondente, ou que apresentará o trabalho no evento), para quem toda correspondência será enviada. A confirmação de aceite ou rejeição será enviada a este autor, que já deverá estar inscrito no evento até 20 de maio de 2013.

2. Nome, instituição, cidade e país dos demais co-autores. Listá-los por sobrenome, iniciais e fornecer e-mail de cada um.

Título do resumo: apenas a primeira letra e os nomes próprios devem ser em maiúsculas. O título deve conter no máximo 250 caracteres, contando os espaços, e deve ser informativo do conteúdo do trabalho.

Texto do resumo: adote a estruturação do resumo, que deve conter: contexto, objetivos, metodologia, resultados e conclusões. Pode-se incluir uma Tabela ou Gráfico e até três referências relevantes. O texto deve ter no máximo 2500 caracteres (incluindo espaços e não contando título, autores e referências). Pode-se indicar o e-mail e a agência de fomento ao final do resumo. Não use códigos do HTML e "end of lines". Os resumos devem ser digitados em espaço simples, caixa baixa, fonte Arial 12, Word 97-2003.

As referências devem ser citadas como se segue:
Silva J et al. Prognostic value of AGTX protein expression in non-small cell lung carcinoma: a prospective study of 534 patients. Braz J Lung Cancer 2009; 23:2

Investimento


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

Categoria Até 31/12/2012 Até 07/06/2013 Na data do evento
Estudantes,Residentes e Pós-Graduandos R$ 300 R$ 350 R$ 450
Médicos e Profissionais da Área da Saúde R$ 500 R$ 550 R$ 650
Sócios CBC / SBCO
- R$ 440 R$ 520
"Day Fee" - 1 dia do Evento - R$ 180 R$ 180

* Obs.: Para as inscrições "Day Fee", por favor, insira no campo "Observação" da Ficha de Inscrição qual é a data escolhida.

Inscrição


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

Preencha a ficha de inscrição, clicando no botão ao lado.

Será gerado um boleto para pagamento. Sua inscrição será confirmada após o pagamento do boleto.

Hotéis para Congressistas


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

Mencionar participação no evento Next Frontiers do Hospital A.C.Camargo.

Hotel Renaissance
Endereço: Alameda Santos, 2233 - Cerqueira Cesar - São Paulo
Tel.: 55 11 3069.2807
Tarifas negociadas com apartamentos Deluxe
Site: www.renaissance.com.br

Hotel Estanplaza
Endereço: Alameda Jau, 497 - Cerqueira Cesar - São Paulo
Tel.: 55 11 3016.0000 / 55 11 3059.3277
Tarifas negociadas com apartamentos Suíte House e Business Plus
Site: www.estanplaza.com.br

Hotel Mercure SP Central Towers
Endereço: Rua Maestro Cardim, 407 - Paraíso - São Paulo
Tel.: 55 11 2853.7000
Tarifas negociadas com apartamentos Classic, Standard, Superior e Suíte Jr
Site: www.mercure.com

Patrocínio e Apoio


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br




Saiba mais sobre os patrocinadores

Merck Serono é uma divisão da Merck KGaA, Darmstadt, Alemanha. Seu foco na oncologia é identificar as moléculas mais importantes envolvidas na formação do câncer, as quais podem ser utilizadas no desenvolvimento de novas terapias de alvo molecular que agem especificamente nas células cancerosas. Essa abordagem tem o potencial de melhorar a eficácia e de também reduzir a incidência de determinados eventos adversos.

As atividades em pesquisa estão focadas em três áreas:
- Compostos que agem diretamente nas células tumorais;
- Compostos que agem indiretamente nas células tumorais através da sua interação com o ambiente tumoral;
- Compostos que estimulam o sistema imunológico.

A abrangência do desenvolvimento dos compostos em oncologia da Merck Serono compreende componentes química e biologicamente ativos. A Merck Serono Oncologia, por meio da abordagem com terapias de alvo molecular, tem como objetivos contribuir para o prolongamento da sobrevida dos pacientes com câncer e aumentar a sua qualidade de vida.

Notícias


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

21/02/2013 - Next Frontiers to Cure Cancer - Integrating Science and Patient Care
Agência FAPESP

21/02/2013 - Next Frontiers to Cure Cancer - Integrating Science and Patient Care
Planeta Universitário

04/03/2013 - NEXT FRONTIERS TO CURE CANCER - INTEGRATING SCIENCE AND PATIENT CARE
Visite São Paulo

06/03/2013 - Cientistas fazem debate em S. Paulo sobre a cura do câncer
Jornal DCI

Releases


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

26.06.2013
Alto custo e baixa resposta com as terapias que fortalecem a prevenção e acompanhamento de grupos de alto risco como medidas mais eficazes

25.06.2013

Com nova abordagem, A.C.Camargo visa ampliar em 4 vezes o sucesso das terapias para controle do dermatofibrosarcoma

13.06.2013
Câncer cerebral mais comum, o glioma é diagnosticado em 7 entre 10 casos em sua forma mais agressiva e o desafio está em identificar terapias mais eficazes

29.05.2013
Obesidade como fator de risco para câncer é um dos temas de evento internacional em SP

28.05.2013
Congresso sobre câncer em SP aborda o suporte físico e emocional ao paciente do diagnóstico ao pós-tratamento

21.05.2013
"Há uma tirania da Medicina baseada em evidências. Nem tudo pode depender de estudos randomizados", afirma epidemiologista Eduardo Franco, da McGill, do Canadá

07.05.2013
Congresso em SP debate de 13 a 15 de junho a ciência levada da bancada de pesquisa para o leito do paciente com câncer

07.05.2013
Ciência aponta caminhos em biologia molecular em câncer de pulmão para reverter alta mortalidade em todo o mundo

24.04.2013
Especialistas relatam experiência com mais de mil pacientes tratados de câncer de pênis em 60 anos

12.04.2013
Cirurgia robótica para câncer de reto será debatida por oncologistas e cientistas em 13 de junho, em SP

09.04.2013
Evento em SP discute desafios do tratamento do tumor desmóide que, embora benigno, é agressivo e com alto potencial de recidiva

19.02.2013
Cientistas de oito países debatem em SP as fronteiras para a cura dos tipos mais comuns de câncer no Brasil

Outras Informações


 

Confira informações sobre o Next Frontiers to Cure Cancer 2017 em www.nextfrontiers.com.br

Superintendência de Marketing - Hospital A.C.Camargo
E-mail: eventos@accamargo.org.br
Tel: +55 (11) 2189-5078